Use of Angiotensin System Inhibitors Is Associated With Immune Activation and Longer Survival in Non-Metastatic Pancreatic Ductal Adenocarcinoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-0256
Full Text
Open PDFAbstract
Available in full text
Date
June 9, 2017
Authors
Publisher
American Association for Cancer Research (AACR)